"Aspergillosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with fungi of the genus ASPERGILLUS.
| Descriptor ID |
D001228
|
| MeSH Number(s) |
C01.703.080
|
| Concept/Terms |
Aspergillosis- Aspergillosis
- Aspergilloses
- Aspergillus Infection
- Aspergillus Infections
- Infection, Aspergillus
- Infections, Aspergillus
|
Below are MeSH descriptors whose meaning is more general than "Aspergillosis".
Below are MeSH descriptors whose meaning is more specific than "Aspergillosis".
This graph shows the total number of publications written about "Aspergillosis" by people in this website by year, and whether "Aspergillosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 3 | 0 | 3 |
| 1995 | 1 | 1 | 2 |
| 1996 | 1 | 0 | 1 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 1 | 0 | 1 |
| 2002 | 4 | 1 | 5 |
| 2003 | 7 | 3 | 10 |
| 2004 | 9 | 3 | 12 |
| 2005 | 11 | 1 | 12 |
| 2006 | 5 | 1 | 6 |
| 2007 | 8 | 1 | 9 |
| 2008 | 8 | 0 | 8 |
| 2009 | 5 | 0 | 5 |
| 2010 | 7 | 0 | 7 |
| 2011 | 4 | 1 | 5 |
| 2012 | 7 | 2 | 9 |
| 2013 | 2 | 2 | 4 |
| 2014 | 6 | 3 | 9 |
| 2015 | 2 | 2 | 4 |
| 2016 | 7 | 1 | 8 |
| 2017 | 4 | 2 | 6 |
| 2018 | 0 | 2 | 2 |
| 2019 | 4 | 2 | 6 |
| 2020 | 2 | 0 | 2 |
| 2021 | 4 | 0 | 4 |
| 2022 | 3 | 0 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aspergillosis" by people in Profiles.
-
A novel lentiviral vector-based approach to generate chimeric antigen receptor T cells targeting Aspergillus fumigatus. mBio. 2024 Apr 10; 15(4):e0341323.
-
Dectin-1/CARD9 induction of the TFEB and TFE3 gene network is dispensable for phagocyte anti-Aspergillus activity in the lung. Infect Immun. 2023 Nov 16; 91(11):e0021723.
-
Development of a Corticosteroid-Immunosuppressed Mouse Model to Study the Pathogenesis and Therapy of Influenza-Associated Pulmonary Aspergillosis. J Infect Dis. 2023 04 12; 227(7):901-906.
-
Statin Use and Aspergillosis Risk-More than Meets the Eye? Clin Infect Dis. 2023 01 13; 76(2):368.
-
Quandaries of deciding when to change first-line therapy in invasive pulmonary aspergillosis. J Antimicrob Chemother. 2022 10 28; 77(11):2897-2900.
-
Triazole Priming as an Adaptive Response and Gateway to Resistance in Aspergillus fumigatus. Antimicrob Agents Chemother. 2022 08 16; 66(8):e0045822.
-
Orbital Aspergillosis, a great masquerader: a series of three unusual cases and a review of the literature. Trop Doct. 2022 Jul; 52(3):418-426.
-
Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study. Mycoses. 2022 Feb; 65(2):186-198.
-
Navigating the Uncertainties of COVID-19-Associated Aspergillosis: A Comparison With Influenza-Associated Aspergillosis. J Infect Dis. 2021 11 22; 224(10):1631-1640.
-
Aspergillus terreus Species Complex. Clin Microbiol Rev. 2021 12 15; 34(4):e0031120.